We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 104

U.S. Supreme Court refines & limits antitrust state action defense
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • February 26 2015

On February 25, 2015, the United States Supreme Court issued a 6-3 opinion in North Carolina State Bd of Dental Examiners v. FTC, which held that a


Clarity on Doctrine of Equivalents Analysis for Chemical Claims
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • May 23 2017

On May 19, 2017, the Federal Circuit addressed and modified a rare grant of a preliminary injunction based on the doctrine of equivalents. In doing so


FTC v. Phoebe Putney Health System, Inc., et al.
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • February 20 2013

On February 19, 2013, the United States Supreme Court in Federal Trade Commission v. Phoebe Putney Health System, Inc., et al., unanimously rejected


FTC v. Actavis
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • June 21 2013

On June 17, 2013, the Supreme Court issued an opinion authored by Justice Breyer in FTC v. Actavis, holding that "reverse payment" settlements are


Dueling court cases issued on same day
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • July 24 2014

On Tuesday morning the U.S. Court of Appeals for the District of Columbia Circuit ruled that an IRS rule for a key piece of the 2010 Affordable Care


Supreme Court decision to drop on Thursday
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • June 25 2012

This morning the Supreme Court issued its ruling on the constitutionally of Arizona’s new immigration law


Separate written description? Oral arguments in en banc rehearing of Ariad v. Lilly
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • December 8 2009

The U.S. Court of Appeals for the Federal Circuit heard oral arguments on December 7 in its en banc rehearing of Ariad Pharmaceuticals Inc. v. Eli Lilly & Co., Fed. Cir., No. 2008-1248


Nondiscrimination rules delayed for insured health plans
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • January 1 2011

The Affordable Care Act imposes, for the first time, nondiscrimination rules on non-grandfathered, insured group health plans similar to those that apply to self-insured plans under Section 105(h) of the Internal Revenue Code (the Code


Medical treatment and diagnostic claims are patentable
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • September 18 2009

The Federal Circuit has calmed some anxiety over the patentability of medical diagnostic methods under 35 U.S.C. 101 with its decision in Prometheus Laboratories, Inc. v. Mayo Collaborative Services, holding that some method of treatment and diagnostic methods are indeed patentable subject matter


TTAB rules that fraud in less than all classes does not warrant cancellation of multi-class registration in toto
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • February 11 2009

On January 29, 2009, the Trademark Trial and Appeal Board (“TTAB”) of the United States Patent and Trademark Office answered a significant open question in the post-Medinol era, namely, whether a finding of fraud with regard to fewer than all International Classes in a multi-Class trademark registration requires cancellation of the entire registration or whether cancellation will be limited to all goodsservices in the Class in which fraud is found